Why is migraine more common in women?

Migraine is twice as prevalent in women than in men.1 Oestrogen is a predisposing factor with decreasing levels associated with increased frequency of migraine episodes. The associations between oestrogen and migraine and why changing oestrogen levels are linked to migraine episodes were explored by Patricia Pozo-Rosich, University of Barcelona, Spain, in an online presentation for live EAN 2020.

Why is migraine more common in women?

Menstruation is a risk factor for migraine without aura5

Among 40,000 people who participated in the 2003 National Health Interview Survey in the US the prevalence of migraine was 9% in males and 18% in females,1 said Dr Pozo-Rosich. It is highest in women between puberty and the menopause,2 reaching a peak of 25% among women in their thirties and forties.3

 

Changing oestrogen levels are linked to migraine episodes

Changing oestrogen levels associated with menarche, oral contraceptive (OC) use, pregnancy, lactation, and menopause are frequently accompanied by changes in the patterns and frequency of migraine:4

  • decreasing oestrogen levels at the onset of menses, during the pill-free interval with OC use, and postpartum are associated with increased frequency of migraine episodes4
  • increasing or stable oestrogen levels during pregnancy, while taking OC, and after the menopause are associated with decreased frequency of migraine episodes4

Perimenstrual migraine episodes are less responsive to treatment than non-menstrual episodes5

Furthermore, menstruation is a risk factor for migraine without aura attacks, said Dr Pozo-Rosich, and can be the only or primary trigger in up to 14% of patients.5

Perimenstrual migraine episodes are longer and less responsive to treatment than non-menstrual episodes.6

 

Why can oestrogens cause migraine?

Oestrogens cause changes in the circulation, nociception, and the brain7-10

Oestrogens appear to cause migraine through a variety of mechanisms including:

  • vasodilatation due to increased endothelial nitric oxide synthase7
  • genetic modulation of serotonin levels involved in nociception8
  • endometrial synthesis of prostaglandin, which sensitises nociceptors and promotes inflammation9
  • cortical excitability10

 

ICHD-3 criteria for diagnosing migraine related to menstruation

For better characterization of migraine associated with menstruation the Appendix of International Classification of Headache Disorders 3rd edition (ICHD-3) offers criteria for diagnosing pure menstrual migraine without aura and with aura, menstrually-related migraine without aura and with aura, and non-menstrual migraine without aura and with aura.11

Our correspondent's highlights from the EAN 2020 symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

AU-NOTPR-0272. February 2021

References
  1. Victor TW, et al. Cephalalgia 2010;30:1065–72.
  2. Lipton RB, Bigal ME. Headache 2005;45 Suppl 1:S3–13.
  3. Jensen R, Stovner LJ. Lancet 2008;7:354–61.
  4. Howard A. Headache 2006;46 Suppl 2:S49–54.
  5. Kornstein SG. J Clin Psychiatry 1997;58 Suppl 15:12–18.
  6. Granella F, et al. Cephalalgia 2004;24:707–16.
  7. Chen Z, et al. J Clin Invest 1999;103:401–6.
  8. Berman NEJ, et al. Headache 2006;46:1230–45.
  9. Boyle. Neuriology 1999;53 4 Suppl 1:S14–18.
  10. Welch KMA, et al. Neurol Sci 2006;27 Suppl 2:S190–2.
  11. Cephalalgia, International Headache Society 2018. 3rd edition. 38(1):1-211.
You are leaving Progress in Mind

Hello
Please, confirm your email address
We are sending you a confirmation link to your email address.
In order to get the access, please, check your email and confirm your registration.
The information on this site is exclusively intended for health care professionals.
All the information in this website is intended exclusively for Australian health care professionals and contains information pertaining to locally marketed products. Content regarding medication is informative. It is the responsibility of healthcare professionals to decide, on an individual basis, the most appropriate treatment to suit the needs of the patient.
Congress
Register for access to Progress in Mind in your country